| Schedule of Computation of Basic and Diluted Net Loss Per Share |
The following table sets forth the computation of basic and diluted net loss per share (in thousands, except share and per share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
|
Nine Months Ended September 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Numerator: |
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(58,568 |
) |
|
$ |
(60,156 |
) |
|
$ |
(230,875 |
) |
|
$ |
(135,620 |
) |
Denominator: |
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-average number of shares of common stock outstanding |
|
|
93,508,939 |
|
|
|
16,229,543 |
|
|
|
45,933,626 |
|
|
|
16,151,112 |
|
Less: Weighted-average number of shares of common stock subject to repurchase |
|
|
(874,244 |
) |
|
|
(1,311,362 |
) |
|
|
(987,408 |
) |
|
|
(1,604,970 |
) |
Less: Weighted-average number of shares of unvested restricted common stock |
|
|
(562,682 |
) |
|
|
(1,343,566 |
) |
|
|
(727,082 |
) |
|
|
(1,986,344 |
) |
Weighted-average common shares outstanding used in calculating net loss per share attributable to common stockholders, basic and diluted |
|
|
92,072,013 |
|
|
|
13,574,615 |
|
|
|
44,219,136 |
|
|
|
12,559,797 |
|
Net loss per share attributable to common stockholders, basic and diluted |
|
$ |
(0.64 |
) |
|
$ |
(4.43 |
) |
|
$ |
(5.22 |
) |
|
$ |
(10.80 |
) |
|
| Schedule of Potentially Anti-dilutive Securities Excluded from Computation of Diluted Weighted Average Shares Outstanding |
The following potentially dilutive securities outstanding have been excluded from the computation of diluted weighted average shares outstanding because such securities have an anti-dilutive effect due to the Company’s net loss, in common stock equivalent shares:
|
|
|
|
|
|
|
|
|
|
|
As of September 30, |
|
|
|
2026 |
|
|
2025 |
|
Redeemable convertible preferred stock |
|
|
— |
|
|
|
38,147,020 |
|
Shares subject to outstanding stock options |
|
|
26,045,046 |
|
|
|
10,974,643 |
|
Shares subject to outstanding common stock warrants |
|
|
1,752,080 |
|
|
|
1,752,080 |
|
Unvested exercised options subject to repurchase |
|
|
833,931 |
|
|
|
1,292,707 |
|
Unvested restricted stock awards |
|
|
497,756 |
|
|
|
1,161,417 |
|
Unvested restricted stock units |
|
|
2,131,436 |
|
|
|
— |
|
Shares subject to employee stock purchase plan |
|
|
757,916 |
|
|
|
— |
|
Total |
|
|
32,018,165 |
|
|
|
53,327,867 |
|
|